Newsroom

News

Every two years, the MDPI Sustainability Foundation presents the Tu Youyou Award for outstanding achievements in the fields of natural product and medicinal chemistry. This year, Rolf Müller is one of two researchers to receive the award for his work on developing new antibiotics based on microbial natural products. The prize was established in 2016 in honor of Chinese Nobel Prize winner Tu Youyou and comes with a total prize money of 100,000 Swiss francs.

30.04.2025

HIPS

Electron microscope image of Fusobacteria.

News

Fusobacteria, which are part of the oral microbiome, are suspected of playing a role in cancer progression. Scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) are working on innovative strategies to inhibit the spread of these bacteria. Antisense molecules, which could serve as programmable, targeted antibiotics, show great promise. In a recent study, a research team led by Jörg Vogel identified a compound that effectively halts the growth of five Fusobacterium species. The findings were published today in the journal mBio.

29.04.2025

HIRI

Dr. Arnaud Carpentier and Frauke Lange in the lab

News

Hepatitis D virus (HDV) infects the liver and causes severe inflammation. According to WHO estimates, 12 million people worldwide are infected with HDV. Currently, there are only a few treatment options. A team of researchers from TWINCORE, the Centre for Experimental and Clinical Infection Research in Hannover, has developed a stem cell-based infection model for HDV and has used it to discover a possible target for an attack on the virus. They are now publishing their results in the scientific journal JHEP Reports. The TWINCORE is a joint institution of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and Hannover Medical School (MHH).

25.04.2025

TWINCORE

Dr. Julia Port and Dr. Marina Greweling-Pils

Interview

Scientists at the Helmholtz Centre for Infection Research (HZI) are studying important mechanisms for the development of infectious diseases and how they can be treated or prevented. Some of the research questions can only be answered with the help of animal experiments. Dr. Julia Port, head of the junior research group “Laboratory of Transmission Immunology”, and Dr. Marina Greweling-Pils, head of the research group “Core Facility of Comparative Medicine” and Animal Welfare Officer at the HZI, explain in an interview to mark the World Day for Laboratory Animals 2025 why not all animal experiments can be replaced and why choosing the right animal model is crucial for reliable scientific results.

23.04.2025

HZI Campus

Teaser for the podcast episode with Kristin Metzdorf

News

Organoids are a pioneering tool in biomedical research. These tiny, organ-like cell structures are grown from stem cells and open up completely new possibilities for studying infectious diseases in human tissue. In this episode of the HZI podcast InFact, Dr Kristin Metzdorf, Deputy Head of the Department “Innovative Organoid Research” at the Helmholtz Centre for Infection Research (HZI), explains why these “mini-organs” are ideal for studying the interplay of the host with viruses or bacteria.

23.04.2025

HZI Campus

News

The Helmholtz Association is pooling its commitment to prevention research with the launch of the Helmholtz Health Prevention Task Force. In a strategy paper published in Nature Medicine, the expert committee outlines initial concepts for more effectively integrating prevention into medical practice.

22.04.2025

HZI Campus

HIOH

Back to the first page
...
24
25
26
27
...
163

HZI in the media

die Bundibugyo-Virusvariante entsteht. Forschende des Helmholtz-Zentrums für Infektionsforschung hatten unlängst Hinweise gefunden , dass

07.10.2026

Medscape

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

07.10.2026

ZDFheute

... Lange, Leiterin der Abteilung Epidemiologie am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und Mitglied der Ständigen ...

07.10.2026

Der Tagesspiegel

in predictable ways. A new study from the Helmholtz Centre for Infection Research (HZI) in Braunschweig now shows that this picture is far

07.10.2026

Scienmag Science Magazine

... nicht isoliert wirken. Wie Forschende des Helmholtz-Zentrums für Infektionsforschung (HZI) gemeinsam mit Teams der Universität ...

06.10.2026

Ad Hoc News

Recent research conducted by the Helmholtz Center for Infection Research (HZI) in collaboration with the European Molecular Biology

06.10.2026

Life Technology™

Technische Universität Braunschweig, das HZI – Helmholtz-Zentrum für Infektionsforschung in Braunschweig sowie die Medizinische Hochschule ...

04.10.2026

schleswig-holstein.de

the Institute of Science and Technology Austria and the Helmholtz Centre for Infection Research in Braunschweig, Germany. Their combined

04.10.2026

Scienmag Science Magazine

... die klinische Validität. Ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) hat mit „Metax“ nun einen ...

02.10.2026

Analytik.de

Mikrobiologen auch Kolleg*innen vom IST Austria und dem HZI in Braunschweig gehören: Inhibitoren von Aktin unterbinden diese dynamischen

01.10.2026

Science.apa.at

... der Medizinischen Hochschule Hannover sowie am Helmholtz-Zentrum für Infektionsforschung tätig ist. Als Co-Autor ist zudem ...

30.09.2026

Ad Hoc News

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

30.09.2026

Phys.org

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.